Published in Br J Haematol on May 01, 1997
Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood (2007) 2.09
Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. J Clin Invest (2012) 1.09
Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices. Am J Physiol Heart Circ Physiol (2008) 1.03
Fluid shear stress and sphingosine 1-phosphate activate calpain to promote membrane type 1 matrix metalloproteinase (MT1-MMP) membrane translocation and endothelial invasion into three-dimensional collagen matrices. J Biol Chem (2011) 0.91
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis. Mediators Inflamm (2015) 0.90
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both. Leukemia (2016) 0.81
Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis. J Exp Med (2016) 0.78
Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications. Oncologist (2015) 0.77
Elevated plasma levels of basic fibroblast growth factor in patients with essential thrombocythaemia and polycythaemia vera. Br J Haematol (1997) 0.75
TPO/Mpl Studies in Agnogenic Myeloid Metaplasia. Cell Commun Signal (2005) 0.75
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms. Mediators Inflamm (2015) 0.75
Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood (1996) 3.13
Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements. Am J Kidney Dis (2001) 2.73
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood (1998) 2.71
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Leukemia (1997) 1.41
Regulation of erythropoiesis by bone marrow reninangiotensin system: facts and speculations. Exp Hematol (1998) 1.39
[Dermatopolymyositis and chronic lymphoid leukemia. Apropos of 2 cases]. Rev Med Interne (1993) 1.39
Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent. Transfusion (2000) 1.25
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Ann Oncol (2005) 1.22
Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med (1997) 1.21
Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res (2000) 1.17
Study of a virus-induced myeloproliferative syndrome associated with tumor formation in mice. Eur J Cancer (1980) 1.14
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem Pharmacol (1992) 1.10
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol (1997) 1.10
What are RBC-transfusion-dependence and -independence? Leuk Res (2010) 1.09
Ki67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors. Am J Clin Pathol (1990) 1.06
RB1 and TP53 pathways in radiation-induced sarcomas. Oncogene (2007) 1.05
Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol (1994) 1.05
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. Br J Haematol (2000) 1.04
Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors. J Cancer Res Clin Oncol (2001) 1.04
Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder. Blood (1989) 1.03
Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies. J Clin Microbiol (1991) 1.02
Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell (1991) 1.01
High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization. Genes Chromosomes Cancer (1999) 1.01
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte. Br J Cancer (1994) 1.01
Role of early splenectomy in malignant lymphomas with prominent splenic involvement (primary lymphomas of the spleen). A study of 59 cases. Cancer (1993) 0.99
The gene for the ligand binding chain of the human interferon gamma receptor. Immunogenetics (1997) 0.97
Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer. Breast Cancer Res Treat (1996) 0.97
Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol (1998) 0.97
Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases. Leukemia (1999) 0.96
Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells. Blood (1994) 0.96
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. Leukemia (2000) 0.96
Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Pathol (1992) 0.96
Therapy-related acute promyelocytic leukemia: a report on 16 cases. J Clin Oncol (1992) 0.95
Expression of platelet-activating factor receptor transcript-1 but not transcript-2 by human bone marrow cells. Stem Cells (1999) 0.92
DNA damage-related RNA expression to assess individual sensitivity to ionizing radiation. Carcinogenesis (2001) 0.91
Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol (1992) 0.91
A T to C mutation in the polypyrimidine tract of the exon 9 splicing site of the RB1 gene responsible for low penetrance hereditary retinoblastoma. J Med Genet (2002) 0.91
Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies. Leukemia (1993) 0.90
M-CSF: haematopoietic growth factor or inflammatory cytokine? Cytokine (1998) 0.90
Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. J Lipid Mediat Cell Signal (1997) 0.89
PAF and haematopoiesis: III. Presence and metabolism of platelet-activating factor in human bone marrow. Biochim Biophys Acta (1995) 0.89
Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension. Blood (1989) 0.88
DNA damage-related gene expression as biomarkers to assess cellular response after gamma irradiation of a human lymphoblastoid cell line. Oncogene (2000) 0.88
Detection of anti-toxoplasma immunoglobulin A antibodies by Platelia-Toxo IgA directed against P30 and by IMx Toxo IgA for diagnosis of acquired and congenital toxoplasmosis. J Clin Microbiol (1995) 0.88
Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines. Cancer Lett (2000) 0.88
Synthesis of abnormal heavy chains in Bence-Jones plasma cell leukemia with intracellular IgG. Blood (1980) 0.87
Up-regulation of aFGF expression in quiescent cells is related to cell survival. J Cell Physiol (1994) 0.87
PAF and haematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells. J Lipid Mediat Cell Signal (1996) 0.86
Macrophage colony-stimulating factor (CSF-1) gene expression in human T-lymphocyte clones. Blood (1991) 0.86
Macrophage colony-stimulating-factor (M-CSF or CSF-1) and its receptor: structure-function relationships. Eur Cytokine Netw (1997) 0.86
Macrophage colony stimulating factor involvement in uremic patients. Kidney Int (1996) 0.85
PAF and hematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells. Exp Hematol (1996) 0.85
IL-6 and IL-8 production by human bone marrow stromal cells. Cytokine (1998) 0.84
Genome instability in secondary solid tumors developing after radiotherapy of bilateral retinoblastoma. Oncogene (2001) 0.84
Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies. Blood (1996) 0.84
Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines. Breast Cancer Res Treat (2001) 0.84
Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations. Eur J Clin Invest (1997) 0.84
Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells. Cytokine (2000) 0.84
Carboxylated nanodiamonds are neither cytotoxic nor genotoxic on liver, kidney, intestine and lung human cell lines. Nanotoxicology (2013) 0.84
Histopathologic studies on myeloproliferative sarcoma virus (MPSV) induced leukemias and hemangiosarcoma in Jar-2 rats. Pathol Res Pract (1988) 0.83
Myeloproliferative Sarcoma Virus stimulates pluripotent hematopoietic stem cells and provokes tumoral transformation of the hematopoietic microenvironment in vitro. Leuk Res (1983) 0.83
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte. J Clin Oncol (2000) 0.83
Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J Immunol (1990) 0.83
Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues. Int J Cancer (1998) 0.83
Effects of lipoxygenase metabolites of arachidonic acid on the growth of human mononuclear marrow cells and marrow stromal cell cultures. Mediators Inflamm (1998) 0.83
Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy. Hematol J (2001) 0.82
Arachidonic acid and freshly isolated human bone marrow mononuclear cells. Mediators Inflamm (1999) 0.82
Effects of platelet-activating factor on human T and B cells--an overview. Res Immunol (1994) 0.82
Immunohistochemical detection of cells positive for colony-stimulating factor 1 in lymph nodes from reactive lymphadenitis, and Hodgkin's disease. Leukemia (1992) 0.82
Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood (1988) 0.82
CD24(-/low) stem-like breast cancer marker defines the radiation-resistant cells involved in memorization and transmission of radiation-induced genomic instability. Oncogene (2012) 0.82
Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells. Exp Hematol (1997) 0.82
Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation. Oncogene (1996) 0.82
Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line. Biochim Biophys Acta (1997) 0.81
PAF and haematopoiesis. X. Macrophage colony-stimulating factor and granulocyte macrophage colony-stimulating factor enhance platelet-activating factor acetylhydrolase production by human blood-derived macrophages. Biochim Biophys Acta (1996) 0.81
In vivo modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5-fluorouracil and Goralatide. Eur J Clin Invest (1998) 0.81
Arachidonic acid and human bone marrow stromal cells. Biochim Biophys Acta (1998) 0.81
Decreased levels of platelet-activating factor in blood of patients with lymphoid and nonlymphoid hematologic malignancies. Blood (1995) 0.81
Effects of MDR reversing agent combinations on the 3H-daunomycin accumulation in drug-sensitive and drug-resistant human cancer cells. Anticancer Res (2000) 0.81
Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures. J Lipid Mediat Cell Signal (1997) 0.81
Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Urology (1997) 0.81
A microarray to measure repair of damaged plasmids by cell lysates. Lab Chip (2008) 0.81
Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies. Leukemia (1997) 0.81
CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells. Blood (1994) 0.81
Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases. Leukemia (2001) 0.81
CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers. Genes Chromosomes Cancer (2000) 0.80
Spontaneous and inducible production of macrophage colony-stimulating factor by human bone marrow stromal cells. Eur Cytokine Netw (1997) 0.80